IYUZEH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Iyuzeh, and what generic alternatives are available?
Iyuzeh is a drug marketed by Thea Pharma and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-four patent family members in twenty-seven countries.
The generic ingredient in IYUZEH is latanoprost. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the latanoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iyuzeh
A generic version of IYUZEH was approved as latanoprost by AMRING PHARMS on March 22nd, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IYUZEH?
- What are the global sales for IYUZEH?
- What is Average Wholesale Price for IYUZEH?
Summary for IYUZEH
International Patents: | 34 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Patent Applications: | 6,239 |
Drug Prices: | Drug price information for IYUZEH |
What excipients (inactive ingredients) are in IYUZEH? | IYUZEH excipients list |
DailyMed Link: | IYUZEH at DailyMed |
US Patents and Regulatory Information for IYUZEH
IYUZEH is protected by one US patents.
Patents protecting IYUZEH
Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thea Pharma | IYUZEH | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 216472-001 | Dec 13, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for IYUZEH
See the table below for patents covering IYUZEH around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2588078 | SYSTEME DE DELIVRANCE POLYMERIQUE D'UNE SOLUTION NON VISQUEUSE A BASE DE PROSTAGLANDINE SANS CONSERVATEUR (POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE-FREE PROSTAGLANDIN-BASED NONVISCOUS SOLUTION) | ⤷ Sign Up |
Japan | 2015038099 | 防腐剤を含まない非粘性プロスタグランジン系点眼液用のポリマー送達システム (POLYMER DELIVERY SYSTEM FOR NON-VISCOUS PROSTAGLANDIN-BASED OPHTHALMIC SOLUTION CONTAINING NO ANTISEPTIC) | ⤷ Sign Up |
Croatia | P20140631 | ⤷ Sign Up | |
Eurasian Patent Organization | 201291307 | СИСТЕМА ПОДАЧИ НЕВЯЗКОГО ПОЛИМЕРНОГО РАСТВОРА НА ОСНОВЕ ПРОСТАГЛАНДИНА, НЕ СОДЕРЖАЩЕГО КОНСЕРВАНТ | ⤷ Sign Up |
Brazil | 112012033435 | solução oftálmica e frasco de dose única ou multi-dose feito de pebd sem aditivos. | ⤷ Sign Up |
China | 104274396 | POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE-FREE PROSTAGLANDIN-BASED NONVISCOUS SOLUTION | ⤷ Sign Up |
Portugal | 2588078 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for IYUZEH
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0364417 | 61/1997 | Austria | ⤷ Sign Up | PRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718 |
0364417 | 97C0128 | France | ⤷ Sign Up | PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718 |
0364417 | 9690031-1 | Sweden | ⤷ Sign Up | PRODUCT NAME: LATANOPROST |
3461484 | 122021000036 | Germany | ⤷ Sign Up | PRODUCT NAME: LATANOPROST, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND NETARSUDIL MESYLAT; REGISTRATION NO/DATE: EU/1/20/1502 20210107 |
3461484 | C202130024 | Spain | ⤷ Sign Up | PRODUCT NAME: NETARSUDIL O UN ENANTIOMERO, DIASTEREIOISOMERO, SAL O SALVADO DEL MISMO EN COMBINACION CON LATANOPROST O UNA SAL DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1502; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1502; DATE OF FIRST AUTHORISATION IN EEA: 20210107 |
3461484 | 2021C/515 | Belgium | ⤷ Sign Up | PRODUCT NAME: ROCLANDA - LATANOPROST / NETARSUDIL; AUTHORISATION NUMBER AND DATE: EU/1/20/1502 20210108 |
0364417 | SPC/GB97/014 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |